𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for non-adherence to medication in inflammatory bowel disease patients

✍ Scribed by R. D’INCÀ; P. BERTOMORO; K. MAZZOCCO; M. G. VETTORATO; R. RUMIATI; G. C. STURNIOLO

Book ID
108605184
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
78 KB
Volume
27
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient trust-in-physician and race are
Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease
✍ Geoffrey C. Nguyen; Thomas A. LaVeist; Mary L. Harris; Lisa W. Datta; Theodore M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Background: Adherence plays an important role in the therapeutic effectiveness of medical therapy in inflammatory bowel disease (IBD). We assessed whether trust-in-physician and Black race were predictors of adherence. ## Methods: We performed a cross-sectional study of Black (n ϭ 120) and W

Patients' attitudes to medicines and adh
Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease
✍ Rob Horne; Rhian Parham; Richard Driscoll; Andrew Robinson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 1 views

Background: Nonadherence has been reported in over 40% of patients taking maintenance therapies (MT) for inflammatory bowel disease (IBD). Studies in other illness groups have shown that nonadherence is related to negative attitudes to treatment. The aim of this study was to assess patients' attitud

Systematic evaluation of risk factors fo
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
✍ Stephan R. Vavricka; Sabrina M. Spigaglia; Gerhard Rogler; Valérie Pittet; Pierr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 808 KB

## Background: The diagnosis of inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), continues to present difficulties due to unspecific symptoms and limited test accuracies. We aimed to determine the diagnostic delay (time from first symptoms to IBD diagn